Wednesday, September 30, 2020

Diseases & Conditions News

Health Europa brings you the latest Diseases & Conditions News from across the field of European Healthcare & Social Care Policy.

The Wellbeing Business: exploring workplace mental health

The Wellbeing Business: exploring workplace mental health

The Wellbeing Business founder Zoe Eccleston speaks with HEQ about the importance of good mental health in the workplace. Workplace health and wellbeing expert Zoe...
The UK Vaccine Taskforce: securing access to vaccines

The UK Vaccine Taskforce: securing access to vaccines

Kate Bingham, Chair of the UK Vaccine Taskforce, discusses the three goals of the taskforce. The UK Vaccine Taskforce has three key goals: to secure...
COVID-19 and mental health at work and school

COVID-19 and mental health at work and school

The COVID-19 pandemic has created a growing mental health crisis. Isolation, uncertainty, and fear have all been significant factors in worsening mental health during the...
Prion disease: potential treatment discovered by researchers

Prion disease: potential treatment discovered by researchers

Researchers have discovered a possible effective treatment strategy for patients suffering from prion disease. The study, published in Nucleic Acids Research by Oxford University Press,...
“The science should not get in the way”

“The science should not get in the way”

With more than a quarter of the world’s confirmed cases of COVID-19, can the USA reopen? More than 25% of all confirmed cases of COVID-19...
Rare diseases: innovation, collaboration, and genomics

Rare diseases: innovation, collaboration, and genomics

Professor Hackett discusses public-private collaboration, secure data sharing, and the potential of genomic sequencing for the treatment of rare diseases. Professor Joanne Hackett, General Partner,...
Promise of a new route of treatment for Huntington’s Disease

Promise of a new route of treatment for Huntington’s Disease

An enzyme has been identified that can pave the way for the development of a new route of treatment for Huntington's Disease. Scientists at EPFL's...
“The case for action on obesity has never been stronger”

“The case for action on obesity has never been stronger”

Public Health England has launched a campaign to address obesity, a key risk factor in COVID-19. Following a growing body of evidence that being overweight...

Fighting for a life unlimited with the Cystic Fibrosis Trust

Dr Lucy Allen, Director of Research at the Cystic Fibrosis Trust, speaks with HEQ about cystic fibrosis research, treatment and innovation. Founded in 1964, the...
Innovation, technology, and evidence-based treatment for spinal cord injury

Innovation, technology, and evidence-based treatment for spinal cord injury

HEQ explores innovation in the treatment of spinal cord injury. Injuries to the spinal cord, whether they are caused by an acute trauma such as...
Farxiga meets endpoints in trial for the treatment of chronic kidney disease

Farxiga meets endpoints in trial for the treatment of chronic kidney disease

Farxiga has been shown to significantly reduce the worsening of renal function or risk of death in patients with chronic kidney disease with and...
Molecular cause explains a genetic form of microcephaly

Molecular cause explains a genetic form of microcephaly

Scientists have helped to explain a genetic form of microcephaly by uncovering a molecular cause for the rare disease. Microcephaly is a condition where babies'...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest